The Multifaceted Potential of Adhatoda vasica Nees: Traditional Uses, Pharmacological Activities and Biotechnological
Sekhar Tiwari1, Priyanka Panchal1, Harsh Mehta1
1Department of Microbiology, School of Sciences, P P Savani University, Kosamba, Surat, 394125, Gujarat, India.
Abstract:
Adhatoda vasica Nees (A. vasica), known as the Malabar nut, belongs to the Acanthaceae family and is widely distributed across South and Southeast Asia. It is used in Ayurveda and Unani medicine as a therapy for human diseases, such as respiratory ailments like asthma, bronchitis, and tuberculosis. These plants are reported to be rich in alkaloids, flavonoids, tannins, and saponins, with vasicine and vasicinone as the primary bioactive compounds for their therapeutic activity. A. vasica has also been identified to contain several secondary metabolites, such as quercetin, kaempferol, and apigenin, that exhibit antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory activities. The transcriptome analysis of A. vasica identified 171,064 transcripts corresponding to 55,528 genes, which are associated with key biosynthetic pathways. Therefore, these A. vasica were overharvested, precisely because of their widespread medicinal use and habitat destruction, and have been placed in the threatened species category in India. This review will emphasize the need for sustainable cultivation practices and biotechnological applications in order to preserve its availability for its therapeutic benefits. Moreover, clinical trials are necessary to validate its effectiveness and safety for its therapeutic applications. Integrating traditional knowledge with modern biotechnological advancements, the A. vasica plant could be a potential contributor to the pharmaceutical industry, developing new drugs with little or no adverse effects that can improve the quality of life of patients during treatment.
Related Concept Videos
01:18Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:24Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...